Research programme: vasopressin analogues - GP Pharm
Latest Information Update: 16 Jul 2016
At a glance
- Originator GP Pharm
- Class Vasopressins
- Mechanism of Action Vasopressin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Hypotension
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Hypotension in Spain (Intranasal, Spray)
- 01 Jan 2012 Early research in Hypotension in Spain (Intranasal)